🇺🇸·1d agoIndustry
Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
Publisher
E
Eli Lilly News
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Eli Lilly News
- Region
- USA
- Scope
- Industry
- Published
- July 9, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on investor.lilly.com
Leave the platform to read the original full article on the publisher site.
Source: Eli Lilly News
Scope: Industry
Related coverage
More related coverage
GSK News/4h ago
GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population
Nippon Shinyaku News/6h ago
人を生かす力が、未来を創る 社員とともに進める人的資本経営─Human Capital Report 2026発行のお知らせ
Menicon/14h ago
Menicon SC GmbH opens a state-of-the-art automated production and dispatch facility at its site in Offenbach am Main, near Frankfurt
Otsuka Holdings RSS/15h ago